ERD

Probabilistic classification of anti‐SARS‐CoV‐2 antibody responses improves seroprevalence estimates

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Nanobodies in the limelight: Multifunctional tools in the fight against viruses

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2.

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodies

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Shared 2019-nCoV spike binding results for nanobodies

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Deliver lead candidate anti-nCoV mAbs (from hybridoma combinatorial library screens) to KI for neutralization screening

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Shared mAb sequences, including NGS data

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Protection against SARS-CoV-2 transmission by a parenteral prime—Intranasal boost vaccine strategy

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Deliver an ongoing series of progressively optimized anti-nCoV mAbs to KI for neutralization screening.

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Predicted antigen-specific antibody variants.

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Shared 2019-nCoV spike binding results for mAbs

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Seropositivity in blood donors and pregnant women during the first year of SARS‐CoV‐2 transmission in Stockholm, Swe...

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Picomolar SARS-CoV-2 Neutralization Using Multi-Arm PEG Nanobody Constructs

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Shared nanobody sequences of confirmed binders, and data from NGS library sequencing

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Shared expression results

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Update of DMP

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization...

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Neutralization results for isolated monoclonal antibodies and camelid nanobodies, as well as modified mAbs

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Longitudinal single-cell analysis of SARS-CoV-2–reactive B cells uncovers persistence of early-formed, antigen-specifi...

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody b...

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

A Multiparametric and High-Throughput Platform for Host–Virus Binding Screens

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Shared plasmids.

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Genetic evidence for the association between COVID-19 epidemic severity and timing of non-pharmaceutical interventions

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Resources

Selected filters:

Probabilistic classification of anti‐SARS‐CoV‐2 antibody responses improves seroprevalence estimates

Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models

Nanobodies in the limelight: Multifunctional tools in the fight against viruses

Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2.

Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodies

Shared 2019-nCoV spike binding results for nanobodies

Deliver lead candidate anti-nCoV mAbs (from hybridoma combinatorial library screens) to KI for neutralization screening

Shared mAb sequences, including NGS data

Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies

Protection against SARS-CoV-2 transmission by a parenteral prime—Intranasal boost vaccine strategy

Deliver an ongoing series of progressively optimized anti-nCoV mAbs to KI for neutralization screening.

Predicted antigen-specific antibody variants.

Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2

Shared 2019-nCoV spike binding results for mAbs

Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape

Seropositivity in blood donors and pregnant women during the first year of SARS‐CoV‐2 transmission in Stockholm, Swe...

Picomolar SARS-CoV-2 Neutralization Using Multi-Arm PEG Nanobody Constructs

Shared nanobody sequences of confirmed binders, and data from NGS library sequencing

Shared expression results

Update of DMP

Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization...

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden

Neutralization results for isolated monoclonal antibodies and camelid nanobodies, as well as modified mAbs

Longitudinal single-cell analysis of SARS-CoV-2–reactive B cells uncovers persistence of early-formed, antigen-specifi...

Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody b...

A Multiparametric and High-Throughput Platform for Host–Virus Binding Screens

Shared plasmids.

Genetic evidence for the association between COVID-19 epidemic severity and timing of non-pharmaceutical interventions